|Rapid Review Complete
|Nivolumab plus ipilimumab
|Opdivo® plus Yervoy®
|For the treatment of advanced melanoma.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Reimbursement Not Recommended at the Submitted Price.
The HSE has approved reimbursement following confidential price negotiations October 2017.